- Home
- TLSI vs PCYO Comparison
TLSI vs PCYO Comparison
Compare TLSI & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- PCYO
- Stock Information
- Founded
- TLSI 2010
- PCYO 1976
- Country
- TLSI United States
- PCYO United States
- Employees
- TLSI N/A
- PCYO N/A
- Industry
- TLSI Medical Specialities
- PCYO Water Supply
- Sector
- TLSI Health Care
- PCYO Utilities
- Exchange
- TLSI Nasdaq
- PCYO Nasdaq
- Market Cap
- TLSI 204.0M
- PCYO 242.7M
- IPO Year
- TLSI N/A
- PCYO N/A
- Fundamental
- Price
- TLSI $4.56
- PCYO $10.12
- Analyst Decision
- TLSI Strong Buy
- PCYO
- Analyst Count
- TLSI 5
- PCYO 0
- Target Price
- TLSI $10.90
- PCYO N/A
- AVG Volume (30 Days)
- TLSI 134.8K
- PCYO 54.8K
- Earning Date
- TLSI 08-13-2025
- PCYO 07-09-2025
- Dividend Yield
- TLSI N/A
- PCYO N/A
- EPS Growth
- TLSI N/A
- PCYO 123.89
- EPS
- TLSI N/A
- PCYO 0.56
- Revenue
- TLSI $32,141,000.00
- PCYO $27,447,000.00
- Revenue This Year
- TLSI $55.39
- PCYO N/A
- Revenue Next Year
- TLSI $54.89
- PCYO N/A
- P/E Ratio
- TLSI N/A
- PCYO $17.70
- Revenue Growth
- TLSI 46.20
- PCYO 40.36
- 52 Week Low
- TLSI $3.50
- PCYO $9.49
- 52 Week High
- TLSI $6.04
- PCYO $14.63
- Technical
- Relative Strength Index (RSI)
- TLSI 39.21
- PCYO 46.29
- Support Level
- TLSI $4.41
- PCYO $9.91
- Resistance Level
- TLSI $4.73
- PCYO $10.13
- Average True Range (ATR)
- TLSI 0.22
- PCYO 0.25
- MACD
- TLSI -0.02
- PCYO -0.03
- Stochastic Oscillator
- TLSI 18.99
- PCYO 22.94
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.